News
From tracking heart rate and sleep patterns to measuring blood oxygen levels, smartwatches are helping people stay more in ...
Timothy Spall reveals he thought he ‘might not make it’ after leukaemia diagnosis - ‘I got down on my knees and asked God to ...
Researchers sought to determine whether MSD HSCT or auto-HSCT would have advantages over chemotherapy in post-remission treatment for patients with AML.
Blood-based proteomic profiling of 251 inflammatory proteins in 543 patients with newly diagnosed acute myeloid leukemia (AML) identifies an eight-protein signature that enhances risk stratification.
Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, and Weill Cornell Medicine have entered into ...
Family and friends of Rachel Simon of Hazlet are staging events to find a bone marrow donor who can help her fight off ...
Actor Timothy Spall thought he ‘might not make it’ after being diagnosed with leukaemia. The award-winning star, 68, who is ...
A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...
People at high risk of acute myeloid leukaemia (AML) can be identified years in advance, but there is currently no treatment ...
A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...
US drug maker AbbVie has launched its key leukemia drug, Venetoclax, in India, marking its entry into the country's oncology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results